BeiGene | Sustainability & Chart

US07725L1026

Basic information on BeiGene

Location: Cayman Islands

Industry: Health Services

Website

Impact Score

Description BeiGene

BeiGene Ltd is a global biotechnology company focused on discovering, developing, and commercializing innovative cancer therapies. It operates in the pharmaceutical industry targeting a wide range of oncological diseases.

BeiGene Sustainability Performance

Climate

16%

Renewable Energy

No data available for BeiGene. Target value per method: min. 100%

Greenhouse Gas Emissions

BeiGene emits 1,8 times its CO₂ budget of 58,323 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Supply Chain

Taking into account the entire supply chain, BeiGene emits 12,5 times its CO₂ budget of 58,323 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

No data available for BeiGene. Target value per method: min. 75%

Society

45%

Union Formation and Collective Bargaining Power

BeiGene issues 0% collective agreements. Target value per method: min. 80%

CEO Pay Ratio

CEO John V. Oyler earns 218 times the median salary of employees. Target value per method: max. 30 times

Employee Turnover Rate

BeiGene has an employee turnover rate of 15%. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

BeiGene meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

67%

Women on Board

BeiGene has 36,4% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

No data available for BeiGene. Target value per method: max. 3%

Women in Management

BeiGene employs 41% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at BeiGene is 69,5% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare BeiGene with ...

BeiGene

?

Impact Score

Climate

Society

Gender

16%

45%

67%

BeiGene

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
CEO Pay Ratio
CEO-to-median-salary-ratio	218	ratio	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	38
CEO name	John V. Oyler		2025	sec-10-k-2025-annual-report.pdf	216
Employee Turnover Rate
Employee turnover	15	%	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	94
Glass Ceiling
Women in management	41	%	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	87
Women in workforce	59	%	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	88
Greenhouse Gas Emissions
Scope 1 emissions	11 539	Tonnes CO2e	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	96
Number of employees	12 000	people	2025	sec-10-k-2025-annual-report.pdf	88
Scope 2 emissions, location based	90 661	Tonnes CO2e	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	96
Harassment and Discrimination at the Workplace
Retaliation safeguards	Yes		2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	59
Confidentiality mechanisms	Yes		2025	BeiGene - Code of Business Conduct and Ethics (Final Final).pdf	7
Anti-discrimination policy	Yes		2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	59
Incident notification mechanism	Yes		2025	sec-10-k-2025-annual-report.pdf	60
Supply Chain
Scope 2 emissions, location based	90 661	Tonnes CO2e	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	96
Number of employees	12 000	people	2025	sec-10-k-2025-annual-report.pdf	88
Scope 3 emissions	627 386	Tonnes CO2e	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	96
Scope 1 emissions	11 539	Tonnes CO2e	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	96
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage	0	%	2025	sec-10-k-2025-annual-report.pdf	60
Women on Board
Executive board size	11	people	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	72
Women on executive board	41	percent	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	87
Women on supervisory board	3	Name	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	56
Supervisory board size	11	people	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	56
Women in Management
Women in management	41	%	2025	BeOneMedicines_2025-SustainabilityReport_V3.3.pdf	87

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Learn to invest Academy Glossary Our Method

Imprint Privacy Policy GTC FAQContact Us

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev